Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
U.S. Healthcare Reform: Reaction to the Patient Protection and Affordable Care Act of 2010
Daemmrich, Arthur A.Caso HBS-711103-EEconomíaSupplement to "U.S. Healthcare Reform: International Perspectives," HBS No. 710-040, updating key events and disputes concerning the reform law, including the 2010 Congressional elections, legislative proposals, legal challenges, and responses by employers.Desde 8,20 €
-
Targanta Therapeutics: Hitting a Moving Target, Teaching Note
Daemmrich, Arthur A.Nota del Instructor HBS-710006-EIniciativa emprendedoraTeaching Note for [709002].Desde 0,00 €
-
U.S. Healthcare Reform: International Perspectives, PowerPoint
Daemmrich, Arthur A.Caso HBS-711105-EEconomíaNo abstract.Desde 8,20 €
-
Targanta Therapeutics: Hitting a Moving Target (PPT)
Daemmrich, Arthur A.Caso HBS-711056-EIniciativa emprendedoraDesde 8,20 €
-
Arcadia Biosciences: Seeds of Change, Teaching Note
Daemmrich, Arthur A.; Reinhardt, Forest L.Nota del Instructor HBS-711042-ETeaching Note for 709019.Desde 0,00 €
-
U.S. Healthcare Reform: International Perspectives, Teaching Note
Daemmrich, Arthur A.; Cameron, EliaNota del Instructor HBS-711062-EEconomíaTeaching Note for #710-040 and 711-103.Desde 0,00 €
-
A Managerial Perspective on Clinical Trials
Daemmrich, Arthur A.Caso HBS-709033-EIniciativa emprendedoraThis note describes the history and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven years, and consumes up to 70 percent of a drug's total development costs, pharmaceutical and biotechnology leaders need to understand clinical trial management. Likewise, with a growing variety of new product i...Desde 8,20 €
-
U.S. Healthcare Reform: International Perspectives
Daemmrich, Arthur A.; Cameron, EliaCaso HBS-710040-EEconomíaThe national economic implications of rising healthcare costs were poorly understood, even as the United States, Germany, and the United Kingdom instituted reforms in early 2010. Presenting opportunities for cross-national policy learning, this case describes the political economy of healthcare reform. In late March 2010, a major healthcare reform act was signed into law in the United States, expanding coverage and regulating insurers. However, i...Desde 8,20 €
-
Arcadia Biosciences: Seeds of Change (Abridged)
Daemmrich, Arthur A.Caso HBS-711050-EArcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers' costs and generate environmental benefits through reduced greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology company, notably uneven enforcement of intellectual property in emerging market countries, and uncertainty regarding the provision and market value of carbon credits under international c...Desde 8,20 €
-
Targanta Therapeutics: Hitting a Moving Target
Daemmrich, Arthur A.Caso HBS-709002-EIniciativa emprendedoraThis case explores regulatory, product testing, and business strategy at Targanta Therapeutics, a biotech company preparing its first new drug application to the FDA. In October 2007, Mark Leuchtenberger, president and CEO of Targanta - which has just held a successful IPO - weighs options for the approximately ten month review period after the company submits to the Food and Drug Administration. The case reviews Targanta's origins and "de-riskin...Desde 8,20 €